Global Contraceptives Market – Industry Trends and Forecast to 2030

Global Contraceptives Market, By Contraceptive Drugs (Contraceptive Pills, Patch, Injectables), Type (Intra-Uterine Devices, Pills, Cervical Caps, Condoms, Diaphragms, Injections), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Contraceptives Market Analysis and Size

As per the World Health Organization, amongst 1.9 billion reproductive-age women of 15 - 49 years worldwide in 2019, about 1.1 billion women require family planning. Contraceptive services and programs are progressively recognizing the importance of human rights. The increased use of contraception has reduced the risk of sexually transmitted infections and improved health-related outcomes comprising maternal & infant mortality.  

Data Bridge Market Research analyses a growth rate in the contraceptives market in the forecast period 2023-2030. The expected CAGR of contraceptives market is tend to be around 6.51% in the mentioned forecast period. The market was valued at USD 28.65 billion in 2022, and it would grow upto USD 47.45 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Contraceptives Market Scope and Segmentation

Market Definition

Contraception aims to prevent pregnancy as birth control pills or tablets. For the prevention of pregnancy, contraception is used as a consequence of sexual intercourse. The major forms of artificial contraception are contraceptive pills, IUDs, barrier methods, implants and sterilization.  

Global Contraceptives Market Dynamics

Drivers

• Increase R&D Activities

The increased R&D activities cause the market to flourish. Numerous treatment options have been studied and research has been carried out to overcome the burden of unwanted pregnancy. During clinical trials, several new types of contraceptive pills and gels will be introduced that are projected to work around new laws and limitations on current birth control procedures. Eventually, research is ongoing to concentrate on developing a non-hormonal pill which could expand the range of birth control options available to men.

• Rising Awareness by Different Organizations

The WHO has launched an app which outlines its medical guidelines for contraception use. Women will benefit from this digital tool because it is effective, safe, and acceptable contraceptives. WHO published a report in 2017, with a user-friendly checklist that primarily focuses on human rights standards in the provision of contraceptive information and services.

Opportunities

• Increase in Initiatives by Organizations

Numerous initiatives, such as Every Woman Every Child, Millennium Development Goals, the 2030 Sustainable Development Goals (SDGs), and Family Planning 2020 (FP2020), have been launched by governments and other healthcare organizations for family planning is promoting the use and manufacturing of contraceptives. For instance, Family Planning 2020 was the initiative launched in 2012 and ran up to 2020, that offered global partnerships to share knowledge and offer a right-based, person-centered approach to family planning. The initiative was later expanded to 2030 to ensure the accessibility of contraceptives and other family planning resources worldwide.

• Growing Adoption of Oral Contraceptives

Oral contraceptives are highly used after by young people in developing nations. The high number of government sponsored programs and the free provision of contraceptives in rural and urban areas will boost growth in the sale and wide use of these pills in the market. In addition to the growing challenges that are related with teenage pregnancies, growing knowledge of modern contraception and the issue of unplanned pregnancies will continue to further pushthe market for oral pills.

Restraints/Challenges

• Lack of Awareness About Contraception

The lack of understanding while using these long-term contraceptive pills causes apprehension about accepting them. In underdeveloped countries, the social stigma associated with the use of contraception methods and the expensive cost of these methods and pills are responsible for the low uptake and acceptability of these methods.

• Side-Effects of Contraceptives

The adverse side-effects associated with the treatment process hinder the market growth. In rare cases, the side effects are very severe such as heart attacks, blood clots in the legs, and stroke, liver disorders, and gallbladder disease. These side effects that are related with the usage of contraceptives will limit the sales during the forecast period.

This contraceptives market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the contraceptives market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Contraceptives Market

COVID-19 has significantly impacted the contraceptives market value. The initiation of novel innovations and technologies during the outbreak become the routine standard of care comprising the use of telemedicine and telehealth in contraception initiation and continuation. Numerous telehealth modalities enable patients to connect using technology to deliver health care. Supporting mobile outreach services to deliver a wide range of contraception products in areas having poor access to healthcare providers has increased the industry value.

Recent Development

• In December 2021, Cooper Surgical, Inc. acquired Generate Life Sciences. This acquisition helps Cooper to improve their reproductive segment. Generate Life Sciences, which is a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage, for a purchase price of around $1.6 billion.

Global Contraceptives Market Scope

The contraceptives market is segmented on the basis of treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Contraceptive Drugs
• Contraceptive Pills
• Patch
• Injectables
• Intra-Uterine Devices
• Copper
• Hormonal
• Pills
• Cervical Caps
• Condoms
• Male
• Female
• Diaphragms
• Injections

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Contraceptives Market Regional Analysis/Insights

The contraceptives market is analyzed and market size insights and trends are provided by treatment, distribution channel and end-user as referenced above.

The major countries covered in the contraceptives market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for contraceptives market throughout the forecasted period due to rising demand of contraceptives among women who are at risk of unplanned pregnancy especially in the U.S. and Canada.

Asia-Pacific dominates the market due to increasing healthcare expenditure focusing women’s health as priority.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Contraceptives Market Share Analysis

The contraceptives market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to contraceptives market

Key players operating in the contraceptives market include:

• Abbvie, Inc (U.S.)
• Afaxys, Inc. (U.S.)
• Merck & Co Inc. (U.S.)
• Teva Pharmaceuticals Industries Ltd. (Israel)
• Bayer AG (Germany)
• Pfizer Inc. (U.S.)
• Agile Therapeutics (U.S.)
• Cupid Ltd. (India)
• Helm AG (Germany)
• Church & Dwight Co., Inc (U.S.)
• Organon group of companies (U.S.)
• Reckitt Benckiser Group PLC (U.K.)
• Veru Inc. (U.S.)